For the second time this month, there’s promising news from a COVID-19 vaccine candidate. Moderna says preliminary phase three trial data shows its coronavirus vaccine is nearly 95% effective in preventing COVID-19.
There’s been lots of buzz about the promising results and while we inch closer to possible approval — Emanuela Campanella looks at the questions left unanswered. .